Abing, Hazel Faith .
HRN: 24-31-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2024
CEFUROXIME 750MG (VIAL)
10/04/2024
10/10/2024
IVTT
450mg
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes